Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD81 and CD28 costimulate T cells through distinct pathways.

D A Witherden1, R Boismenu, W L Havran

  • 1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|August 5, 2000
PubMed
Summary

CD81 acts as a costimulatory molecule in T cell activation, independent of CD28. This pathway uniquely enhances IFN-gamma and TNF-alpha production, offering a novel target for immune modulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protection against colitis by CD100-dependent modulation of intraepithelial γδ T lymphocyte function.

Mucosal immunology·2013
Same author

Peripheral secretin-induced Fos expression in the rat brain is largely vagal dependent.

Neuroscience·2004
Same author

A secretin i.v. infusion activates gene expression in the central amygdala of rats.

Neuroscience·2003
Same author

Orally administered RDP58 reduces the severity of dextran sodium sulphate induced colitis.

Annals of the rheumatic diseases·2002
Same author

Intraepithelial gamma delta T cells exposed by functional genomics.

Genome biology·2001
Same author

A role for epithelial gamma delta T cells in tissue repair.

Springer seminars in immunopathology·2000

Area of Science:

  • Immunology
  • Cellular Biology
  • Molecular Biology

Background:

  • CD81 molecule expression on T cells increases post-activation.
  • This suggests a potential role for CD81 in T cell activation progression.

Purpose of the Study:

  • To investigate the function of CD81 in murine splenic alphabeta T cell activation.
  • To determine if CD81 acts as a costimulatory molecule and characterize its pathway.

Main Methods:

  • In vitro costimulation assay using murine splenic T cells.
  • Analysis of T cell activation markers and cytokine production (IL-2, IFN-gamma, TNF-alpha).
  • Comparison of CD81 costimulation with CD28-mediated costimulation and its sensitivity to cyclosporin A.

Main Results:

Related Experiment Videos

  • CD81 functions as a costimulatory molecule for both CD4+ and CD8+ T cells.
  • CD81-mediated costimulation is independent of CD28 and inhibited by cyclosporin A.
  • CD81 costimulation uniquely up-regulates IFN-gamma and TNF-alpha, but not IL-2.

Conclusions:

  • CD81 mediates an alternative costimulatory pathway for T cell activation.
  • This pathway presents a distinct mechanism for regulating T cell responses.
  • CD81 represents a potential therapeutic target for modulating immune responses.